21 completed, 9 unknown, 4 active not recruiting, 3 recruiting. 17 Not applicable, 17 Phase 2, 5 Phase 1, 3 Phase 4, 2 Phase 3.
Follow sulforaphane: new trials by email Literature Review of sulforaphane trials Research Report on sulforaphane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in Schizophrenia Placebo, Sulforaphane - Schizophrenia Disorder | Not applicable | Not yet recruiting | Second Xiangya Hospital of Central South University | 60 | 2026-06-02 | 2026-06-18 |
| Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma Biopsy Procedure, Biospecimen Collection, Placebo Administration - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8 | Phase 2 | Recruiting | ECOG-ACRIN Cancer Research Group | 120 | 2026-02-20 | 2026-09-15 |
| Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation Sulforaphane - ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myelogenous Leukemia | Not applicable | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 36 | 2025-10-22 | 2025-12-30 |
| Study of the Efficacy of Sulforaphane in Children Aged 6 to 12 With Attention Deficit Disorder With or Without Hyperactivity Sulforaphane, Placebo - Attention Deficit Disorder | Not applicable | Unknown | Assistance Publique - Hôpitaux de Paris | 70 | 2024-12-01 | 2024-09-19 |
| Mechanism Study of Sulforaphane in ASD Improvement Sulforaphane - Autism Spectrum Disorder, Sulforaphane | Not applicable | Withdrawn | Jian-Jun Ou | 2024-09-20 | 2025-09-04 | |
| Safety, Feasibility, and Tolerability of Sulforaphane in Children with Chronic Kidney Disease Sulforaphane - Pediatric Kidney Disease | Phase 2 | Active not recruiting | University of Rochester | 12 | 2023-05-15 | 2024-09-19 |
| Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease Sulforaphane (Avmacol Extra Strength), Placebo - Chronic Kidney Disease Stage 3, Chronic Kidney Disease Stage 4 | Phase 2 | Completed | University of Rochester | 96 | 2023-05-03 | 2026-05-18 |
| Treatment Strategy to Enhance Nrf2 Signaling in Older Adults Sulforaphane, Placebo capsules - Aging Problems | Not applicable | Completed | Northern Arizona University | 32 | 2023-02-09 | 2025-08-28 |
| Validation Digital Bio-markers During Sulforaphane Treatment. Sulforaphane - Autism, Autism Spectrum Disorder | Not applicable | Enrolling by invitation | Rutgers, The State University of New Jersey | 10 | 2022-07-07 | 2025-10-30 |
| Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES Sulforaphane - Diastolic Dysfunction, Systolic Dysfunction | Phase 1 / Phase 2 | Withdrawn | Texas Tech University Health Sciences Center | 2022-07-01 | 2026-06-29 | |
| Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction sulforaphane, Placebo Oral Tablet - Anthracycline Related Cardiotoxicity in Breast Cancer | Phase 1 / Phase 2 | Recruiting | Texas Tech University Health Sciences Center | 70 | 2022-06-01 | 2026-06-29 |
| Study of Sulphoraphane in Chronic Kidney Disease Sulforaphane - Chronic Kidney Disease stage3, Chronic Kidney Disease stage4 | Phase 1 | Completed | University of Rochester | 18 | 2022-05-02 | 2024-08-12 |
| Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients Sulforaphane, Placebo - HIV Infections | Phase 4 | Unknown | Sunshine Specialty Health Care | 20 | 2022-02-21 | 2022-02-07 |
| A 6-month Study to Evaluate Sulforaphane Effects in PD Patients Sulforaphane, Placebo - Parkinson Disease | Phase 2 | Unknown | Central South University | 100 | 2021-11-28 | 2023-07-06 |
| The PROtective Effect of SulforAphaNe on Chronic Low-grade Inflammation in Healthy Participants BroccoCress, Affilla Cress - Inflammation | Not applicable | Completed | Maastricht University Medical Center | 12 | 2021-11-11 | 2022-04-13 |
| Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2 Sulforaphane, administered as Broccoli sprout extract - Chronic Kidney Disease Stage 3B, Chronic Kidney Disease stage4 | Not applicable | Completed | Karolinska Institutet | 100 | 2021-10-10 | 2024-03-04 |
| Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS Sulforaphane - Fragile X Associated Tremor/Ataxia Syndrome (Fxtas) (Diagnosis) | Not applicable | Completed | University of California, Davis | 15 | 2021-06-25 | 2023-07-12 |
| A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients Sulforaphane, placebo - Schizophrenia | Phase 2 | Completed | Central South University | 125 | 2020-08-31 | 2023-04-26 |
| A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression sulforaphane, placedo, selective 5 - HT reuptake inhibitors (SSRI) - Depressive Disorder | Phase 2 | Unknown | Central South University | 90 | 2020-07-15 | 2020-08-20 |
| Effects of Sulforaphane on Cognitive Function in Patients With Frontal Brain Damage sulforaphane, placedo - Frontal Lobe Dysfunction | Phase 2 | Unknown | Xiangya Hospital of Central South University | 90 | 2020-06-01 | 2020-05-19 |
Showing 20 of 42. Sign in to see all of them.
Autism Spectrum Disorder (6) · Autistic Disorder (4) · Schizophrenia (3) · Diabetes Mellitus, Type 2 (2) · Prostatic Neoplasms (2) · Renal Insufficiency, Chronic (2) · Alzheimer Disease (1) · Anemia, Refractory, with Excess of Blasts (1) · Attention Deficit Disorder with Hyperactivity (1) · Cardiotoxicity (1) · Child Development Disorders, Pervasive (1) · Cognition Disorders (1) · Cystic Fibrosis (1) · Depression (1) · Depressive Disorder (1)
Central South University (5) · University of Rochester (3) · Johns Hopkins University (2) · Rutgers, The State University of New Jersey (2) · Texas Tech University Health Sciences Center (2) · Anders Rosengren, MD PhD (1) · Assistance Publique - Hôpitaux de Paris (1) · ECOG-ACRIN Cancer Research Group (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Jian-Jun Ou (1) · Jian-Min Yuan, MD (1) · Karolinska Institutet (1) · Kyunghee University Medical Center (1) · Maastricht University Medical Center (1) · Northern Arizona University (1)
United States (20) · China (10) · United Kingdom (3) · Netherlands (1) · South Korea (1) · Sweden (1)
Anna Chien (2) · Renrong Wu, M.D Ph.D (2) · Alexander MacGregor, PhD (1) · Anders Rosengren (1) · Andrew W Zimmerman, MD (1) · Carla Avesani, PhD (1) · Daomeng Cheng, M.D. (1) · David Heber, MD, PhD (1) · David L Eaton, PhD (1) · Fang Dong (1) · Fengyu Zhang, Ph.D. (1) · Hua Jin, M.D Ph.D (1) · Hua Jin, M.D., Ph. D. (1) · Hua Jin, PhD (1) · Jackilen Shannon, PhD (1)
PMID 24287881, PMID 25313065, PMID 28615356, PMID 29854372, PMID 31155953, PMID 32242086, PMID 33067279, PMID 34034808, PMID 37485383, PMID 38089924, PMID 39832347, PMID 40041932, PMID 41099966, PMID 41802185
R01DK128677 (2), 5KL2TR001109-05 (1), P01CA090890 (1), R01CA213123 (1), UG1CA189828 (1)